KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentChange in Working CapitalChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Gains from Investment Securities (2019 - 2024)

Aurora Cannabis has reported Gains from Investment Securities over the past 6 years, most recently at $5.7 million for Q4 2024.

  • Quarterly Gains from Investment Securities rose 279.96% to $5.7 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$8.4 million through Dec 2024, up 56.33% year-over-year, with the annual reading at $1.4 million for FY2023, 48.12% down from the prior year.
  • Gains from Investment Securities was $5.7 million for Q4 2024 at Aurora Cannabis, up from -$1.6 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $5.7 million in Q4 2024 and troughed at -$22.8 million in Q3 2021.
  • The 5-year median for Gains from Investment Securities is -$1.7 million (2020), against an average of -$3.1 million.
  • Year-over-year, Gains from Investment Securities plummeted 1088.16% in 2023 and then soared 279.96% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $456522.1 in 2020, then crashed by 838.56% to -$3.4 million in 2021, then tumbled by 129.82% to -$7.7 million in 2022, then soared by 58.98% to -$3.2 million in 2023, then soared by 279.96% to $5.7 million in 2024.
  • Per Business Quant, the three most recent readings for ACB's Gains from Investment Securities are $5.7 million (Q4 2024), -$1.6 million (Q2 2024), and -$3.2 million (Q4 2023).